165 results
Page 4 of 9
8-K
EX-99.1
067oct2pc9suilgh
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
8-K
EX-2.1
b48jqnfz6lb4m7 q5
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
8-K
EX-99.1
43l3v3 vb2917
30 Sep 21
Regulation FD Disclosure
1:30pm
8-K
EX-99.1
aggq1 2hw8vpe68x
24 Sep 21
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
4:07pm
10-K
9ey gvyoq3rbp
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
cbpuui1ru oemd
24 Sep 21
Annual report
7:31am
8-K
EX-99.1
9bujc
20 Sep 21
Regulation FD Disclosure
1:09pm
8-K
EX-99.2
7p62k9m
20 Sep 21
Regulation FD Disclosure
1:09pm
8-K
EX-99.1
rne7ya36vclpp oc
13 Sep 21
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
8:00am
8-K
EX-99.1
cvw9szplic35 45pt
10 Sep 21
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
6:13am
8-K
EX-99.1
5wc12jb
8 Sep 21
Regulation FD Disclosure
6:04am
8-K
EX-99.1
nl0fwpd
12 Aug 21
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
3:33pm
424B3
ie3s rjwc
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
m092o2w808 n4c7p
2 Jul 21
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement
4:27pm